June 17, 2020
AVEO Announces Pricing of $44.6 Million Public Offering of Common Stock
Aveo expects the gross proceeds from the offering to be approximately $44.6 million.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
June 17, 2020
Merck and Pfizer’s SGLT2 Inhibitor STEGLATROTM (ertugliflozin) Meets Primary Endpoint in VERTIS CV Trial for Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Results Presented at the American Diabetes Association’s Virtual 80th Scientific Sessions KENILWORTH, N.J. & NEW YORK–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK),…
June 16, 2020
Sanofi invests in vaccine production in France, €490 million over five-years
Sanofi on Tuesday detailed plans investing in France to increase its vaccines research and production capacities, and contribute in responding to future pandemic risks, aligned with its corporate strategy presented last December, Sanofi will invest €610 million to create a new production site and research center in France with both dedicated to vaccines.
June 16, 2020
TILT Biotherapeutics Secures Over EUR 6 million to Advance Cancer Immunotherapies Into Clinic
Tilt Biotherapeutics has secured an additional EUR 6.2m, including EUR 4.5m equity, to advance its proprietary, best-in-class cytokine armed oncolytic adenovirus, TILT-123, into Phase 1 clinical trials
June 16, 2020
Dr. Reddy’s Laboratories Limited announces filing of Annual Report on Form 20-F
HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that its Annual Report on Form…
June 15, 2020
German Federal Government invests €300 Million in CureVac
The Federal Republic of Germany will invest 300 million Euros in the biopharmaceutical company CureVac AG, a pioneer in the preclinical and clinical development of mRNA-based drugs.
June 15, 2020
Hikma, Sun Pharma in licensing agreement for Ilumya for the MENA region
Hikma Pharmaceuticals and a wholly-owned subsidiary of Sun Pharmaceutical Industries Ltd. (Sun Pharma), the world’s fourth largest specialty generic pharmaceutical company, announced today that they have entered into an exclusive licensing and distribution agreement for Ilumya, an innovative biologic product, for the Middle East and North Africa (MENA) region.
June 15, 2020
Vyripharm Biopharmaceuticals, Regis Technologies in COVID-19 related deal
Vyripharm Biopharmaceuticals and Regis Technologies, Inc. Have Signed Off on a Master Drug Program Agreement for Expediting cGMP Manufacture of Our Antiviral Agents for Diagnostic Evaluation of COVID-19.
June 15, 2020
Pharmaceutical Supply Chain Trends 2020: Patient-centric supply chains will be key to thrive in the post COVID-19 world, says Quantzig
LONDON–(BUSINESS WIRE)–#Analytics–One of the world’s leading analytics solutions provider, Quantzig, announces the completion of its recent article that presents comprehensive…
June 15, 2020
Epsilen Bio appoints Julia Berretta as Chief Executive Officer and Mathieu Simon as Chairman of the Board
Company announces strategic collaboration with SR-Tiget MILAN–(BUSINESS WIRE)–#investing—Epsilen Bio, a biotechnology company developing transformative therapies for patients affected by underserved…